🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to assess the safety, tolerability, and pharma...
Status
Completed
Location
Multiple Locations
Start Date
2012-08
Trial ID
NCT02140125
This study study aims to elucidate the immune responses to a shared antigen...
Status
Completed
Location
Washington University School of Medicine
Start Date
2018-09-14
Trial ID
NCT03532217
This study is researching an experimental drug called ALN-PNP. This study i...
Status
Completed
Location
Chungbuk National University Hospital
Start Date
2024-05-21
Trial ID
NCT06024408
Main purpose of the study is to look for an optimal dose for the treatment ...
Status
Completed
Location
Department of Obstetrics & Gynaecology, CUHK, Prince of Wales Hospital
Start Date
2006-06
Trial ID
NCT00420576
Treatments Being Tested
This clinical study investigates the anti-inflammatory and anti-cancer prop...
Status
Not Yet Recruiting
Location
Linkou Chang Gung Memorial Hospital
Start Date
2026-01-01
Trial ID
NCT07248020
Treatments Being Tested
The purpose of this study is to evaluate the safety and plasma concentratio...
Status
Completed
Location
Multiple Locations
Start Date
2006-11
Trial ID
NCT01514825
This study compares the long-axis and short-axis technique of continues add...
Status
Completed
Location
Xulei CUI
Start Date
2016-07
Trial ID
NCT02799797
This is an open- label, non- randomized, uncontrolled, dose-escalation pilo...
Status
Unknown
Location
Multiple Locations
Start Date
2023-11-20
Trial ID
NCT06119659
Treatments Being Tested
The optimal antihypertensive treatment strategy in young and middle-aged hy...
Status
Not Yet Recruiting
Location
Peking University People's Hospital
Start Date
2024-01
Trial ID
NCT05416840
Treatments Being Tested
The purpose of this study is to evaluate in a randomized, double-blind fash...
Status
Completed
Location
Novartis Investigative Site
Start Date
2010-08
Trial ID
NCT01151410